The Association between Selective Serotonin Reuptake Inhibitors (SSRIs) Use and the Risk of Bladder Cancer: A Nationwide Population-Based Cohort Study
Background: Past studies suggest mixed associations between selective serotonin reuptake inhibitor (SSRI) prescription and carcinogenic risk. There is no epidemiological study reporting on the association between SSRI use and the incidence of bladder cancer. The aim of this study is to determine whe...
Main Authors: | Yi-Chun Liu, Vincent Chin-Hung Chen, Mong-Liang Lu, Min-Jing Lee, Roger S. McIntyre, Amna Majeed, Yena Lee, Yi-Lung Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-05-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/5/1184 |
Similar Items
-
Selective serotonin reuptake inhibitors (SSRIs) and breast cancer : a record linkage study
by: Ashbury, Janet E.
Published: (2008) -
Design and Synthesis of Arylamidine Derivatives as Serotonin/Norepinephrine Dual Reuptake Inhibitors
by: Hui Wen, et al.
Published: (2019-01-01) -
Selective serotonin reuptake inhibitors and spermatogenesis
by: M. N. Korshunov, et al.
Published: (2021-07-01) -
The Role of Selective Serotonin Reuptake Inhibitors in Premature Ejaculation
by: Alka Aggarwal, et al.
Published: (2017-08-01) -
Acute effects of selective serotonin reuptake inhibitors on neuroleptic-induced catalepsy in mice
by: J.G.P. Pires, et al.
Published: (2005-12-01)